EPCAM and cancer: We demonstrated that the expression levels of the cancer stem-like cell markers CD44, OCT4, Nanog and ABCG2, as well as the EMT regulatory factor Slug were significantly enhanced in EpCAM-overexpressing cells and reduced in EpCAM-depleted HONE1 cells compared with control cells (Fig. 4a).